NCT02208167View on ClinicalTrials.gov

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 7, 2015

Primary Completion Date

January 19, 2017

Study Completion Date

November 27, 2017

Conditions
HIV
Interventions
BIOLOGICAL

HXTC infusion

Trial Locations (1)

27599-7030

University of North Carolina, Chapel Hill

All Listed Sponsors
collaborator

CARE Collaboratory of AIDS Researchers for Eradication

UNKNOWN

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT02208167 - Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy | Biotech Hunter | Biotech Hunter